Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adrenoceptor beta 3 | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 6 % | Agonistic activity at human Beta-1 adrenergic receptor at 1000 nM concentration | ChEMBL. | 15546708 |
Activity (functional) | = 6 % | Agonistic activity at human Beta-1 adrenergic receptor at 1000 nM concentration | ChEMBL. | 15546708 |
Activity (functional) | = 17 % | Agonistic activity at human Beta-2 adrenergic receptor at 1000 nM concentration | ChEMBL. | 15546708 |
Activity (functional) | = 17 % | Agonistic activity at human Beta-2 adrenergic receptor at 1000 nM concentration | ChEMBL. | 15546708 |
EC50 (functional) | = 2.8 nM | Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-3 adrenergic receptor | ChEMBL. | 15546708 |
EC50 (functional) | = 2.8 nM | Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-3 adrenergic receptor | ChEMBL. | 15546708 |
IA (functional) | = 82 % | Intrinsic activity expressed as percentage of maximal stimulation with isoproterenol of Beta-3 adrenergic receptor | ChEMBL. | 15546708 |
IA (functional) | = 82 % | Intrinsic activity expressed as percentage of maximal stimulation with isoproterenol of Beta-3 adrenergic receptor | ChEMBL. | 15546708 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.